Rheumatoid arthritis (RA) is a chronic autoimmune condition that predominantly affects joints, but its impact extends to multiple organ systems through extra-articular manifestations such as ...

A retrospective analysis suggested that administering rituximab to patients with rheumatoid arthritis complicated by lymphoma, systemic vasculitis, or extra-articular lesions was associated with ...

Rheumatoid arthritis is known as a condition where your immune system attacks your joints. While joint pain and stiffness may be the most common symptoms, it can also cause issues with your skin.

The hallmark symptoms of rheumatoid arthritis (RA) are painful, stiff, and swollen joints, but this autoimmune condition can damage other tissues and organs as well, including the body's largest organ ...

Rheumatoid arthritis (RA) is an autoimmune condition that develops when your immune system attacks healthy cells in your joints. Biological females have about a 3.6% lifetime risk of developing RA, ...

Researchers at the University of Wisconsin School of Medicine and Public Health examined records of rheumatoid arthritis (RA) patients from the national Veterans Health Administration (VHA) system to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Patients with rheumatoid arthritis, gout, ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this 12-part journey ...

It’s not common, but some people with rheumatoid arthritis also develop other autoimmune conditions. These include inflammatory bowel disease (IBD), which refers to conditions that involve long-term ...

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes inflammation, pain, and stiffness in the joints. But RA is a systemic disease — it affects the whole body — and can damage ...

LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global vasculitis treatment market is projected to grow to USD 517.64 million by 2021, at a CAGR of more than 4 ...